CYP2C93

CYP2C93 is a gene that encodes an enzyme belonging to the cytochrome P450 superfamily. This family of enzymes is primarily involved in the metabolism of various endogenous and exogenous compounds, including drugs, toxins, and other chemicals. The CYP2C93 gene is part of the CYP2C subfamily, which is characterized by its role in the oxidative metabolism of a wide range of substrates.

The CYP2C93 enzyme is predominantly expressed in the liver, where it contributes to the biotransformation of pharmaceuticals and metabolic processes. Its specific functions and substrates are still under investigation, but it is believed to play a role similar to other members of the CYP2C subfamily, such as CYP2C9 and CYP2C19, which are known for their influence on drug efficacy and toxicity.

Genetic variations within the CYP2C93 gene may affect enzyme activity, leading to differences in metabolic rates among individuals. Such polymorphisms could potentially influence drug response and susceptibility to adverse drug reactions, making CYP2C93 a subject of interest in pharmacogenomics research.

As of current scientific knowledge, CYP2C93 is considered an orphan enzyme, with limited functional characterization available. Research continues to explore its physiological and pharmacological relevance, aiming to better understand its impact on drug metabolism and personalized medicine.

Overall, CYP2C93 is a member of the cytochrome P450 enzyme family with emerging significance in understanding individual differences in drug metabolism and response.